Reduction in the burden of hospital admissions due to cervical disease from 2003-2014 in Spain.

about

Reduction in the burden of hospital admissions due to cervical disease from 2003-2014 in Spain.

Item

http://www.wikidata.org/entity/Q47367286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Reduction in the burden of hos ...... sease from 2003-2014 in Spain.

@en

Reduction in the burden of hos ...... sease from 2003-2014 in Spain.

@nl

type

Item

label

Reduction in the burden of hos ...... sease from 2003-2014 in Spain.

@en

Reduction in the burden of hos ...... sease from 2003-2014 in Spain.

@nl

prefLabel

Reduction in the burden of hos ...... sease from 2003-2014 in Spain.

@en

Reduction in the burden of hos ...... sease from 2003-2014 in Spain.

@nl

P1476

Reduction in the burden of hos ...... sease from 2003-2014 in Spain.

@en

P2093

Noelia López

http://www.w3.org/2001/XMLSchema#string

Raquel Pascual-García

http://www.w3.org/2001/XMLSchema#string

Ruth Gil-Prieto

http://www.w3.org/2001/XMLSchema#string

Ángel Gil-de-Miguel

http://www.w3.org/2001/XMLSchema#string

P2860

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

[The quality assessment from the minimum basic hospital discharge data set]

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

Using hospital discharge data for disease surveillance.

Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.

Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.

A review of clinical trials of human papillomavirus prophylactic vaccines.

P304

917-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1412897

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29206085

http://www.w3.org/2001/XMLSchema#string

P932

5893208

http://www.w3.org/2001/XMLSchema#string